Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis

被引：0

作者：

Alkhouri, Naim ^{[1
]}

Wong, Vincent Wai-Sun ^{[2
]}

Jablkowski, Maciej ^{[3
]}

de Guevara, Alma Laura Ladron ^{[4
]}

Sheikh, Muhammad ^{[5
]}

Hodge, Alex ^{[6
]}

Elkhashab, Magdy ^{[7
]}

Strasser, Simone ^{[8
]}

Park, Grace S. ^{[9
]}

Landgren, Henrik ^{[10
]}

Tan, Bill ^{[11
]}

Massetto, Benedetta ^{[11
]}

Pecoraro, Maria Lucia ^{[11
]}

Seyedkazemi, Star ^{[11
]}

Martins, Eduardo Bruno ^{[11
]}

Fischer, Laurent ^{[11
]}

Abdelmalek, Manal ^{[12
]}

Tetri, Brent ^{[13
]}

Anstee, Quentin ^{[14
]}

机构：

[1] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[3] Med Univ Lodz, Lodzkie, Poland

[4] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[5] Fresno Clin Res Ctr, Fresno, CA USA

[6] Monash Univ, Monash Med Ctr, Melbourne, Vic, Australia

[7] Toronto Liver Ctr, Toronto, ON, Canada

[8] Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia

[9] Allergan PLC, Irvine, CA USA

[10] Allergan PLC, Marlow, Bucks, England

[11] Allergan PLC, San Francisco, CA USA

[12] Duke Univ, Durham, NC USA

[13] St Louis Univ, St Louis, MO 63103 USA

[14] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI214

引用

页码：S508 / S508

页数：1

共 50 条

[1] Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
Tacke, Frank
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 301 - 311
[2] Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
Anstee, Quentin M.
Neuschwander-Tetri, Brent A.
Wong, Vincent Wai-Sun
Abdelmalek, Manal F.
Younossi, Zobair M.
Yuan, Jiacheng
Pecoraro, Maria Lucia
Seyedkazemi, Star
Fischer, Laurent
Bedossa, Pierre
Goodman, Zachary
Alkhouri, Naim
Tacke, Frank
Sanyal, Arun
CONTEMPORARY CLINICAL TRIALS, 2020, 89
[3] Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
Friedman, Scott
Sanyal, Arun
Goodman, Zachary
Lefebvre, Eric
Gottwald, Mildred
Fischer, Laurent
Ratziu, Vlad
CONTEMPORARY CLINICAL TRIALS, 2016, 47 : 356 - 365
[4] Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH): AURORA Phase 3 Study Design
Anstee, Quentin M.
Neuschwander-Tetri, Brent A.
Wong, Vincent Wai-Sun
Abdelmalek, Manal F.
Younossi, Zobair
Alkhouri, Naim
Yuan, Jiacheng
Pecoraro, Maria Lucia
Seyedkazemi, Star
Fischer, Laurent
Bedossa, Pierre
Goodman, Zachary
Sanyal, Arun
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1601 - S1602
[5] Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis
Eguchi, Akiko
Du Jeu, Xavier De Mollerat
Johnson, Casey D.
Nektaria, Andronikou
Feldstein, Ariel E.
JOURNAL OF HEPATOLOGY, 2016, 64 (03) : 699 - 707
[6] Biomarkers and clinical characteristics associated with non-alcoholic steatohepatitis fibrosis progression in the CENTAUR study
Lanthier, Nicolas
Kluwe, Johannes
Fowell, Andrew
Jablkowski, Maciej
Wong, Vincent Wai-Sun
Yuan, Jiacheng
Muthian, Sean
Nicandro, Jean Paul
Seyedkazemi, Star
Martins, Eduardo Bruno
Fischer, Laurent
Loomba, Rohit
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E793 - E794
[7] Cenicriviroc placebo for the treatment of non-alcoholic steatohepatitis with liver fibrosis: Results from the Year 1 primary analysis of the Phase 2b CENTAUR study Abstracts
Sanyal, Arun J.
Ratziu, Vlad
Harrison, Stephen
Abdelmalek, Manal F.
Aithal, Guruprasad P.
Caballeria, Juan
Francque, Sven M.
Farrell, Geoffrey C.
Kowdley, Kris V.
Craxi, Antonio
Simon, Krzysztof
Fischer, Laurent
Melchor-Khan, Liza
Vest, Jeffrey
Wiens, Brian L.
Vig, Pamela
Seyedkazemi, Star
Goodman, Zachary D.
Wong, Vincent W.
Loomba, Rohit
Tacke, Frank
Friedman, Scott L.
Lefebvre, Eric
HEPATOLOGY, 2016, 64 (06) : 1118A - 1119A
[8] Treatment of non-alcoholic steatohepatitis by β-glucosylceramide:: A phase I/II clinical study
Zigmond, Ehud
Lalazar, Gadi
Pappo, Orit
Zangen, Sarah W.
Sklair, Miriam Levy
Hemed, Nilla
Rabbani, Elazar
Itamar, Raz
Ilan, Yaron
Margalit, Maya
HEPATOLOGY, 2006, 44 (04) : 657A - 658A
[9] CENICRIVIROC TREATMENT FOR ADULTS WITH NON-ALCOHOLIC STEATOHEPATITIS: YEAR 2 ANALYSIS OF THE PHASE 2B CENTAUR STUDY
Lefebvre, Eric
Ratziu, Vlad
Sanyal, Arun J.
Francque, Sven M.
Wong, Vincent
Loomba, Rohit
Goodman, Zachary
Aithal, Guruprasad P.
Harrison, Stephen A.
Abdelmalek, Manal F.
Friedman, Scott L.
Tacke, Frank
GASTROENTEROLOGY, 2018, 154 (06) : S1085 - S1085
[10] Cenicriviroc treatment for adults with non-alcoholic steatohepatitis: Year 2 analysis of the Phase 2b CENTAUR study
Ratziu, V.
Sanyal, A.
Francque, S.
Sun, W.
Wong, V.
Loomba, R.
Goodman, Z.
Lefebvre, E.
Aithal, G.
Harrison, S.
Abdelmalek, M.
Friedman, S.
Tacke, F.
JOURNAL OF HEPATOLOGY, 2018, 68 : S1 - S2

← 1 2 3 4 5 →